Clinical Trial Search

Primary: Percentage of Participants With Change of Treated Lesions — 44; 44; 13 % of participants

Primary: Sensitivity and Specificity — 98.2; 9.5 Ratio * 100 — p=0.05

Primary: The Primary Endpoint for This Study Will be a Change From Baseline in the Number of Pigmented Lesions on Skin Previously Covered by Psoriatic Plaques. — 0 participants

Primary: Change in Wrinkles From Baseline to 12 Weeks Post-study Treatment Assessed by Blinded Photographic Evaluation Using 9-Point Fitzpatrick Wrinkle Scale

Primary: Pigmented Lesion Improvement by Blinded Evaluation — 41 Observations

Primary: Percent Clearance of All Lesions — 88; 96; 92.5; 0 percentage of lesion clearance

Primary: Frequency of BRAF Mutations Among Nevi — 6; 19 BRAF mutations

Primary: Clearance Based on Photographic Scale — 2; 2; 4; 7 Participants

Primary: SciBase Sensitivity and Specificity — 96.6; 31.4 Percentage of total lesions — p=<0.0001

Primary: Number of Participants With Suspicious Tumors Detected After Inspection of Problem Area and Inspection of the Full Body. — 810; 631 participants — p=<0.01

Primary: Change in Spots - Front of Face (Part 1) — 53.60; 58.47; 56.44 spots

Primary: Clearance of SK Lesions — 82 percentage of SK lesion clearance

Primary: Number of Accumulated New Skin Lesions at Month 3 — 65; 103 new skin lesions — p=0.0120

Primary: This is a Study to Measure the Efficacy of the Nd:YAG Laser to Cause Complete Regression of Basal Cell Carcinoma. — 28 tumors

Primary: Lab* Values of Lesional Area Using Dermoscopy and ImageJ — 68.850; 72.103; 73.147; 72.633 unitless

Primary: Number of Participants That Performed a Skin Self-Examination at 3-months — 161; 185 Participants — p=0.12

Primary: Number of Participants Who Completed SSE at Specified Time Points — 217; 242; 475; 238 Participants — p=<0.001

Primary: Comparison of Biopsy/Referral Sensitivity of MelaFind and Dermatologists (Pigmented Skin Lesion Experts and General Dermatologists) — 0.72; 0.97; 0.51; 0.09 Proportion…

Primary: Proportion of Subjects With Lesion Clearance — 16 Participants

Primary: The Percentage of Eligible and Contacted Patients Who Were Randomised Into the Trial — 100 Participants

Primary: Pigmented Lesion Improvement by Blinded Evaluation — 41 observations

Primary: Part 1: Photosensitizer Uptake and Conversion to Protoporphyrin IX — 304 Densitometry units/micrometer squared — p=0.0001

Primary: Percentage of Participants With Histologically Confirmed Complete Response (CR) — 67; 18 percentage of participants — p=<0.001

Primary: Area Under the ROC Curve (AUC) for Melanoma Detection — 0.8482 Probability area (value from 0 to 1)

Primary: Molecular Changes From NB-UVB Therapy

Primary: Accuracy of Skin Cancer Diagnosis: In-Person Assessment — 93 percentage of skin lesions

Primary: Correct Identification of Baseline Photographs vs. Photographs Taken 3 Months Post Last Treatment — 80 % of photos correctly identified

Primary: Number Participants With Hypertropic Scarring, Keloid Formation, Hyper- or Hypopigmentation in Patients With Fitzpatrick Skin Types IV, V, and VI Receiving Nasolabial…

Primary: Diagnostic Accuracy to Detect Melanoma — 20; 92; 1; 140 number of skin lesions

Primary: Investigator Global Assessment Scale for Severity of Facial Acne — 0; 0; 11; 9 Participants